Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Timothy M. Pierpont"'
Autor:
Timothy M. Pierpont, Amy M. Lyndaker, Claire M. Anderson, Qiming Jin, Elizabeth S. Moore, Jamie L. Roden, Alicia Braxton, Lina Bagepalli, Nandita Kataria, Hilary Zhaoxu Hu, Jason Garness, Matthew S. Cook, Blanche Capel, Donald H. Schlafer, Teresa Southard, Robert S. Weiss
Publikováno v:
Cell Reports, Vol 21, Iss 7, Pp 1896-1909 (2017)
Summary: Testicular germ cell tumors (TGCTs) are among the most responsive solid cancers to conventional chemotherapy. To elucidate the underlying mechanisms, we developed a mouse TGCT model featuring germ cell-specific Kras activation and Pten inact
Externí odkaz:
https://doaj.org/article/6126267323864a9aa46bf41ab42d71cb
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Rituximab is a chimeric mouse/human monoclonal antibody (mAb) therapy with binding specificity to CD20. It was the first therapeutic antibody approved for oncology patients and was the top-selling oncology drug for nearly a decade with sales reaching
Externí odkaz:
https://doaj.org/article/b75208d6641e4b62be73c3099d58aef3
Autor:
Timothy M. Pierpont, Candice Limper, Jessica Elmore, Amie Redko, Orchi Anannya, Brian Imbiakha, Alanis Villanueva, Sasha Anronikov, Narda Bondah, Sue Chang, Julie Sahler, Avery August
Publikováno v:
Immunobiology. 228:152356
Autor:
Anabella Maria D Galang, Timothy M. Pierpont, Robert S. Weiss, Amanda R Loehr, Andrew D. Miller, Irma Fernandez, Eric Gelsleichter, Elizabeth S. Moore, Matthew Z Guo
Publikováno v:
Cancers
Cancers, Vol 13, Iss 2045, p 2045 (2021)
Volume 13
Issue 9
Cancers, Vol 13, Iss 2045, p 2045 (2021)
Volume 13
Issue 9
Simple Summary Testicular germ cell tumors (TGCTs) are the most common solid malignancy in young men. Fortunately, these tumors are highly curable with conventional genotoxic chemotherapy. However, because these chemotherapeutics have significant sho
Publikováno v:
Methods in Molecular Biology ISBN: 9781071608593
Testicular germ cell tumors (TGCTs) are among the most curable solid cancers and are typically highly responsive to conventional DNA-damaging chemotherapies, even in patients with metastatic disease. It has therefore been of great interest to underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a4b035effe861e7f54e071686f75db6
https://doi.org/10.1007/978-1-0716-0860-9_11
https://doi.org/10.1007/978-1-0716-0860-9_11
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2195
Testicular germ cell tumors (TGCTs) are among the most curable solid cancers and are typically highly responsive to conventional DNA-damaging chemotherapies, even in patients with metastatic disease. It has therefore been of great interest to underst
Autor:
Robert S. Weiss, Timothy M. Pierpont, Claire M. Anderson, Amy M. Lyndaker, Jason A. Garness, Hilary Zhaoxu Hu, Jamie L. Roden, Teresa L. Southard, Matthew S. Cook, Nandita Kataria, Elizabeth S. Moore, Donald H. Schlafer, Lina Bagepalli, Blanche Capel, Alicia M Braxton, Qiming Jin
Publikováno v:
Cell Reports, Vol 21, Iss 7, Pp 1896-1909 (2017)
Summary: Testicular germ cell tumors (TGCTs) are among the most responsive solid cancers to conventional chemotherapy. To elucidate the underlying mechanisms, we developed a mouse TGCT model featuring germ cell-specific Kras activation and Pten inact
Autor:
Leandro Cerchietti, Ankur Singh, David M. Bassen, Jonathan T. Butcher, Ye F. Tian, Fnu Apoorva, Timothy M. Pierpont, Robert S. Weiss
Publikováno v:
Journal of Biomedical Materials Research Part A. 105:1833-1844
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma, with multiple molecular subtypes. The activated B-cell-like DLBCL subtype accounts for roughly one-third of all the cases and has an inferior prognosis. There is
Autor:
Nancy L. Bartlett, Timothy M. Pierpont, Daniel L. Hertz, Sin-Ho Jung, Andrew D. Zelenetz, Nicholas B. Larson, John P. Leonard, Wyndham H. Wilson, Shaun M. Riska, Kristy L. Richards
Publikováno v:
Journal of Clinical Oncology. 38:e13535-e13535
e13535 Background: Pediatric patients (pts) receiving long-term vincristine treatment for acute lymphoblastic leukemia (ALL) who carry two variant alleles of CEP72 rs924607 experience more severe peripheral neuropathy (PN) at lower cumulative vincris
Autor:
Yuan Fu, Marcus J. C. Long, Jordana C. Bloom, Somsinee Wisitpitthaya, Islam M. Elsaid, Robert S. Weiss, Huma Inayat, Yimon Aye, Timothy M. Pierpont, Joaquin Ortega
Since the origins of DNA-based life, the enzyme ribonucleotide reductase (RNR) has spurred proliferation because of its rate-limiting role in de novo deoxynucleoside-triphosphate (dNTP) biosynthesis. Paradoxically, the large subunit, RNR-α, of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca17b7025f1904bff1cfd6777963422b
https://europepmc.org/articles/PMC6171530/
https://europepmc.org/articles/PMC6171530/